Effects of dietary equol on body weight gain, intra-abdominal fat accumulation, plasma lipids, and glucose tolerance in ovariectomized Sprague-Dawley rats
Authors:
- 1 September 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Menopause
- Vol. 14 (5) , 925-932
Abstract
Objective: To evaluate the effects of dietary equol, a metabolite of the phytoestrogen daidzein, on body weight gain, intra-abdominal fat accumulation, plasma leptin, lipids, and glucose tolerance in ovariectomized rats and to compare them to the effects of 17β-estradiol. Design: Twenty-eight female Sprague-Dawley rats were ovariectomized and fed soy-free chow with the addition of estradiol-3 benzoate (E2B) (10 mg/kg, n = 10) or equol (400 mg/kg, n = 10). The control group (n = 8) received soy-free chow only. Weight and food intake were recorded once weekly. After 6 weeks, intra-abdominal fat was measured using computed tomography, and the intraperitoneal glucose tolerance test was performed. In the seventh week, the animals were killed, blood was collected for plasma, and uteri were removed. Results: Dietary equol significantly increased uterine mass. This effect was, however, 3.5 times lower in magnitude compared to E2B. Similar to E2B, dietary equol decreased weight gain, intra-abdominal fat accumulation, and plasma leptin levels. Equol-treated animals had also lower plasma total cholesterol and triglyceride levels compared to controls. E2B treatment also decreased plasma total cholesterol as well as high-density lipoprotein and low-density lipoprotein cholesterol. In the glucose tolerance test, the area under the curve was significantly smaller in the E2B- and equol-treated animals compared to controls. Also, E2B-treated animals had lower fasting plasma insulin levels. Conclusions: In ovariectomized rats, dietary equol administration attenuates weight gain and shows favorable metabolic effects. However, because of its mild uterotrophic activity, its use in the prevention of postmenopausal weight gain and related metabolic disorders in women with an intact uterus is questionable in terms of safety and warrants further studies.Keywords
This publication has 51 references indexed in Scilit:
- Effects of Dietary Equol on the Pituitary of the Ovariectomized RatsHormone and Metabolic Research, 2007
- Recommendations for estrogen and progestogen use in peri-and postmenopausal women: October 2004 position statement of The North American Menopause SocietyMenopause, 2004
- Estrogenicity of the Isoflavone Metabolite Equol on Reproductive and Non-Reproductive Organs in Mice1Biology of Reproduction, 2004
- Effects of Estrogen Replacement Therapy on Abdominal Fat Compartments as Related to Glucose and Lipid Metabolism in Early Postmenopausal WomenHormone and Metabolic Research, 2002
- Critical Review and Evaluation of the Uterotrophic Bioassay for the Identification of Possible Estrogen Agonists and Antagonists: In Support of the Validation of the OECD Uterotrophic Protocols for the Laboratory RodentCritical Reviews in Toxicology, 2002
- Regulation of UCP1, UCP2, and UCP3 mRNA Expression in Brown Adipose Tissue, White Adipose Tissue, and Skeletal Muscle in Rats by EstrogenBiochemical and Biophysical Research Communications, 2001
- Hormonal and neuroendocrine regulation of energy balance‐the role of leptinArchives of Animal Nutrition, 1998
- Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French womenAtherosclerosis, 1995
- Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptorThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Role of estrogens in androgen-induced spontaneous activity in male rats.Journal of Comparative and Physiological Psychology, 1975